GRIN2B
GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B, also GluN2B, NR2B or NMDAR2B) encodes a GluN2 subunit of the NMDA receptor, a calcium-permeable, ligand-gated cation channel. It contributes to excitatory synaptic transmission and synaptic plasticity in the central nervous system. Browse Assay Genie's current range of GRIN2B research reagents below, or read on for the biology behind the target.
GRIN2B is a component of N-methyl-D-aspartate (NMDA) receptors, which function as heterotetrameric, ligand-gated cation channels with high calcium permeability and voltage-dependent block by Mg(2+). Channel activation requires L-glutamate binding to the GluN2 subunit, glycine or D-serine binding to the GluN1 subunit, and membrane depolarisation to relieve Mg(2+) inhibition. Open receptors mediate potassium efflux alongside the influx of calcium and sodium. Each GluN2 subunit confers distinct channel properties, including activation, deactivation and desensitisation kinetics, pH sensitivity, Ca2+ permeability and binding to allosteric modulators.
The GRIN2B protein belongs to the glutamate-gated ion channel family (NR2B/GRIN2B subfamily) and is part of the HGNC group of glutamate ionotropic receptor NMDA type subunits. NMDA receptors are heterotetramers assembled from seven differentially expressed subunits: NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C or GRIN2D) and NR3 (GRIN3A or GRIN3B). UniProt locates the protein at the cell membrane, including the postsynaptic membrane and dendrites, as well as in late endosomes, lysosomes and the cytoskeleton. The mouse and rat orthologs are both named Grin2b.
Functionally, the subunit participates in synaptic plasticity underlying learning and memory, contributing to long-term depression (LTD) of hippocampal membrane currents. The gene is expressed early in development, which suggests roles in brain development, circuit formation, cellular migration and differentiation. In concert with DAPK1 at extrasynaptic sites, it acts as a central mediator of stroke damage: phosphorylation at Ser-1303 by DAPK1 enhances synaptic NMDA receptor activity and injurious Ca2+ influx, leading to irreversible neuronal death. Naturally occurring GRIN2B mutations are associated with autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy and schizophrenia. Earlier names include glutamate receptor, ionotropic, N-methyl D-aspartate 2B.
GRIN2B contributes to hippocampal long-term depression, making it a focus for studies of learning and memory formation.
Mutations in GRIN2B are associated with autism spectrum disorder, ADHD, epilepsy and schizophrenia, and early expression points to roles in brain development.
With DAPK1, extrasynaptic GRIN2B mediates stroke damage, as Ser-1303 phosphorylation enhances injurious Ca2+ influx and neuronal death.
GluN2 subunits shape NMDA receptor kinetics, pH sensitivity, calcium permeability and allosteric modulation, so GRIN2B is central to channel pharmacology.
GRIN2B encodes the GluN2B subunit of NMDA receptors, calcium-permeable cation channels activated by glutamate, glycine or D-serine and depolarisation. It supports excitatory synaptic transmission and synaptic plasticity, including hippocampal long-term depression, and is implicated in learning and memory.
GRIN2B is also called GluN2B, NR2B and NMDAR2B. The HGNC full name is glutamate ionotropic receptor NMDA type subunit 2B, previously glutamate receptor, ionotropic, N-methyl D-aspartate 2B. UniProt lists the protein as glutamate receptor ionotropic, NMDA 2B.
Naturally occurring GRIN2B mutations are associated with autism spectrum disorder, ADHD, epilepsy and schizophrenia, and the protein mediates stroke damage with DAPK1. Mouse and rat both have a Grin2b ortholog; check the datasheet of any product for its validated reactivity.
Other NMDA receptor subunits and related glutamate receptor targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13224; product specifications from Assay Genie datasheets.